Picture of Cryosite logo

CTE Cryosite Cashflow Statement

0.000.00%
au flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Annual cashflow statement for Cryosite, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

C2021
June 30th
2022
June 30th
2023
June 30th
2024
June 30th
2025
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Changes in Working Capital0.050
Other Operating Cash Flow
Cash from Operating Activities0.5152.521.412.742.06
Capital Expenditures-0.397-0.863-0.301-0.452-0.586
Purchase of Fixed Assets
Software Development Costs
Other Investing Cash Flow Items0.0230.003-0.9221.180.166
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-0.374-0.86-1.220.727-0.42
Financing Cash Flow Items-0.035-0.005-0.028-2.470
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-0.295-0.181-0.796-3.5-1.29
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-0.1811.46-0.61-0.0280.357